|
Q2 FY2027
As of Aug 31, 2026
|
Q1 FY2027
As of May 31, 2026
|
Q4 FY2026
As of Feb 28, 2026
|
Q3 FY2026
As of Nov 30, 2025
|
Q2 FY2026
As of Aug 31, 2025
|
Q1 FY2026
As of May 31, 2025
|
Q4 FY2025
As of Feb 28, 2025
|
Q3 FY2025
As of Nov 30, 2024
|
Q2 FY2025
As of Aug 31, 2024
|
Q1 FY2025
As of May 31, 2024
|
Q4 FY2024
As of Feb 29, 2024
|
Q3 FY2024
As of Nov 30, 2023
|
Q2 FY2024
As of Aug 31, 2023
|
Q1 FY2024
As of May 31, 2023
|
Q4 FY2023
As of Feb 28, 2023
|
Q3 FY2023
As of Nov 30, 2022
|
Q2 FY2023
As of Aug 31, 2022
|
Q1 FY2023
As of May 31, 2022
|
Q4 FY2022
As of Feb 28, 2022
|
Q3 FY2022
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Cash and cash equivalents (note 2) | ||||||||||||||||||||
| Short-term Investments | ||||||||||||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | ||||||||||||||||||||
| Other receivables (note 5) | ||||||||||||||||||||
| Other receivables (note 3) | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Other current assets (note 3) | ||||||||||||||||||||
| Assets held for sale, current (note DNU) | ||||||||||||||||||||
| Assets, Current, Total | ||||||||||||||||||||
| Restricted cash equivalents (note 2) | ||||||||||||||||||||
| Long-term investments (note 2) | ||||||||||||||||||||
| Other long-term assets (note 3) | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Property, plant and equipment, net (note 3) | ||||||||||||||||||||
| Intangible assets, net (note 3) | ||||||||||||||||||||
| Goodwill (note 3) | ||||||||||||||||||||
| Assets held for sale, non-current (note DNU) | ||||||||||||||||||||
| Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities (note 3) | ||||||||||||||||||||
| Income taxes payable (note 4) | ||||||||||||||||||||
| Debentures (note 5) | ||||||||||||||||||||
| Deferred revenue, current (note 10) | ||||||||||||||||||||
| Liabilities held for sale, current (note DNU) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue, non-current (note 10) | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Long-term notes (note 6) | ||||||||||||||||||||
| Long-Term Notes | ||||||||||||||||||||
| Liabilities held for sale, non-current (note DNU) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Capital stock and additional paid-in capital | ||||||||||||||||||||
| Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable | ||||||||||||||||||||
| Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 587,032,279 voting common shares (February 28, 2026 - 587,431,120) | ||||||||||||||||||||
| Deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss (note 8) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
| Common outstanding (in shares) | ||||||||||||||||||||
| Issued and outstanding - 587,032,279 voting common shares (February 28, 2026 - 587,431,120) |
Loading...
